Hygene Biomedicine Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
139
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$111M
Hygene Biomedicine General Information
Description
Provider and researcher of the growth hormone products intended to serve the biotechnology industry. The company is mainly focused on the research and development of various hormone products, providing clients with industry-leading standard products and solutions.
Contact Information
Website
www.biohygene.com(Operating Subsidiary)
Corporate Office
- No. 16 Biovalley Avenue, Torch Development Zone
- Zhongshan
- Zhongshan, Guangdong 528400
- China
Corporate Office
- No. 16 Biovalley Avenue, Torch Development Zone
- Zhongshan
- Zhongshan, Guangdong 528400
- China
Hygene Biomedicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 11-Jan-2025 | $111M | Completed | Profitable | ||
| 2. Secondary Transaction - Private | 08-Feb-2021 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 25-Jul-2017 | Completed | Generating Revenue |
Hygene Biomedicine Signals
Hygene Biomedicine Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jingxi Capital | Venture Capital | Minority |
Hygene Biomedicine FAQs
-
When was Hygene Biomedicine founded?
Hygene Biomedicine was founded in 2004.
-
Where is Hygene Biomedicine headquartered?
Hygene Biomedicine is headquartered in Zhongshan, China.
-
What is the size of Hygene Biomedicine?
Hygene Biomedicine has 139 total employees.
-
What industry is Hygene Biomedicine in?
Hygene Biomedicine’s primary industry is Drug Discovery.
-
Is Hygene Biomedicine a private or public company?
Hygene Biomedicine is a Private company.
-
What is the current valuation of Hygene Biomedicine?
The current valuation of Hygene Biomedicine is .
-
What is Hygene Biomedicine’s current revenue?
The current revenue for Hygene Biomedicine is .
-
Who are Hygene Biomedicine’s investors?
Jingxi Capital has invested in Hygene Biomedicine.
-
When was Hygene Biomedicine acquired?
Hygene Biomedicine was acquired on 11-Jan-2025.
-
Who acquired Hygene Biomedicine?
Hygene Biomedicine was acquired by Sansure Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process